Pharmafile Logo
Pharmafocus logo
Advanced Search

Eisai extends neuroscience partnership with UCL

May 25, 2011
Research and Development Eisai, UCL, academic alliance, academic research, neurodegenerative diseases

Eisai and University College London are to extend their partnership in neuroscience research. The Japanese company’s Neuroscience Product Creation Unit …

News

Contract research news in brief

May 25, 2011
Research and Development contract research, contract research news

Mergers and acquisitions abound in our latest round-up of contract research sector news, as players try to achieve the global …

News

Mark Duckham joins Adventis Health

May 25, 2011
Medical Communications appointment, medical communications

Adventis Health has appointed Mark Duckham to the newly-created role of client services director. In his new position Mark will …

Appointment
Roche's MabThera’s (rituximab)

NICE U-turn on Roche’s MabThera

May 25, 2011
Sales and Marketing MabThera, NICE, Roche

NICE has provisionally recommended Roche’s MabThera as a maintenance therapy for blood cancer patients. The new draft guidance backs MabThera’s …

News

Pfizer will invest $21m in US injectables upgrade

May 25, 2011
Manufacturing and Production APIs, Pfizer, pharma manufacturing

Pfizer has announced another upgrade of its sterile injectables plant in Portage, Michigan, earmarking around $21 million for new air …

News

IPA Best of Health Awards shortlist revealed

May 25, 2011
Medical Communications Best of Health, IPA

The short list of agencies selected for this year’s IPA Best of Health Awards has been revealed. The IPA’s awards …

News

Wainwright Associates offer more Free Pharmacovigilance and Regulatory Affairs Webinars

May 24, 2011
Business Services Wainwright Associates; free webinars for Pharmacovigilance and Regulatory Affairs

Following the success of the “The roles and responsibilities of an EEA Qualified Person for Pharmacovigilance (QPPV)”  webinar delivered on …

News
Press release

J&J and Vertex’s hep C drug Incivek approved by FDA

May 24, 2011
Sales and Marketing FDA, Incivek, Johnson & Johnson, Vertex, hepatitis C, telaprevir

The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …

News

CHMP roundup

May 24, 2011
Sales and Marketing CHMP, EMA, Fampyra, Vibativ, Victrelis, Xgeva, Yervoy

The latest products to be recommended for European approval include MSD’s Victrelis, Astellas Pharma Europe’s Vibativ, Amgen Europe’s Xgeva and …

News

Pfizer and BMS to give Eliquis a rolling launch in Europe

May 24, 2011
Sales and Marketing Eliquis, Pfizer, apixaban, atrial fibrillation

Pfizer and Bristol-Myers Squibb are gearing up to give their new oral anticoagulant Eliquis a rolling launch in Europe, starting …

News
AstraZeneca's Nexium (esomeprazole)

Job cuts at AstraZeneca’s US manufacturing plant

May 24, 2011
Manufacturing and Production AstraZeneca, job cuts

AstraZeneca says it will cut around 135 positions at its manufacturing facility in Westborough, Massachusetts, from the end of this …

News
Sanner's CR-FlipTop caps

Interpack 2011: new product showcase

May 24, 2011
Manufacturing and Production Interpack, manufacturing and production

This year’s Interpack exhibition in Duesseldorf featured the usual crop of new product launches from processing and packaging equipment suppliers. …

News

Uptake of pharma chemicals by crops “an environmental concern”

May 24, 2011
Manufacturing and Production manufacturing and production, pharma manufacturing

Chemicals which enter the environment in the wastewater of pharmaceutical production facilities can be taken up by crops and other …

News
Eli Lilly headquarters

Lilly cuts jobs in Ireland

May 23, 2011
Manufacturing and Production Ireland, job cuts, lilly, manufacturing and production

Eli Lilly has said it is downsizing its plant in County Cork, Ireland, by around 14% in light of patent …

News

European recommendation for GSK’s lupus drug Benlysta

May 23, 2011
Sales and Marketing Benlysta, CHMP, GlaxoSmithKline, Lupus

GlaxoSmithKline’s first-in-class lupus drug Benlysta has been given a major boost by regulators in the European Union. The European Medicines …

News

Pfizer and BMS’ blood thinner Eliquis approved in Europe

May 23, 2011
Sales and Marketing BMS, Eliquis, Pfizer, apixaban

Pfizer and Bristol-Myers Squibb’s eagerly anticipated blood thinner Eliquis has gained European approval. A twice-daily oral Factor Xa inhibitor, Eliquis …

News

Lansley announces U-turn on cancer networks

May 23, 2011
Cancer, NHS, NHS reforms

Health secretary Andrew Lansley has declared that cancer networks will be maintained, reversing an earlier decision to axe them. Lansley …

News
medeconnect_nicola_miles

Nicola Miles joins MedeConnect

May 23, 2011
Sales and Marketing appointment, sales and marketing

MedeConnect Healthcare Insight, the market research division of Doctors.net.uk, has strengthened its senior research team with the appointment of Nicola …

Appointment

Pharma manufacturing investment in emerging markets

May 23, 2011
Manufacturing and Production emerging marketing, pharma manufacturing

The pharmaceutical industry needs to undertake a radical overhaul in its approach to manufacturing which at present is ‘‘inefficient, underutilised …

Feature

Digital Pharma: Pfizer scores with football game

May 20, 2011
Medical Communications Back In Play, Digital Pharma blog, ManMOT, Pfizer, digi game

Pfizer’s football-themed campaign to raise awareness of ankylosing spondylitis has picked up one of a brace of awards for the …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026